𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients

✍ Scribed by Ga-Eon Kim; Kyung Hwa Lee; Yoo Duk Choi; Ji Shin Lee; Jae Hyuk Lee; Jong Hee Nam; Chan Choi; Min Ho Park; Jung Han Yoon

Publisher
Springer
Year
2011
Tongue
English
Weight
314 KB
Volume
459
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Molecular detection of p16 promoter meth
Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients
✍ Hiroshi Nakayama; Kenji Hibi; Tsunenobu Takase; Taiji Yamazaki; Yasushi Kasai; K πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 73 KB πŸ‘ 1 views

## Abstract We previously proved that p16 promoter methylation present in the tumors of colorectal cancer patients can be detected in the serum of those same patients using methylation‐specific PCR (MSP). To seek the possibility that this technique could be applied to the monitoring of cancer recur

Correlation of serum levels of CA-549 to
Correlation of serum levels of CA-549 to disease status in posttreatment serial samples from breast cancer patients
✍ Kurtis R. Bray; Pramod K. Gaur πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 435 KB

CA-549 is a high molecular weight, circulating marker for breast cancer defined by its reactivity to monoclonal antibody BC4E 549. CA-549 has recently been shown to be elevated in the sera of 50% of advanced breast cancer patients (n = 80), as compared to < 2.0% of benign breast disease patients (n